Academic literature on the topic 'Cyclic guanosine 3''
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Cyclic guanosine 3'.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Cyclic guanosine 3'"
Boadu, Emmanuel, Svanhild Vaskinn, Elisabeth Sundkvist, Ragnhild Jaeger, and Georg Sager. "Inhibition by guanosine cyclic monophosphate (cGMP) analogues of uptake of [3H]3′,5′-cGMP without stimulation of ATPase activity in human erythrocyte inside-out vesicles11Abbreviations: 3′,5′-cGMP, guanosine 3′,5′-cyclic monophosphate; 2′,3′-cGMP, guanosine 2′,3′-cyclic monophosphate; N-mb-cGMP, N2-monobutyryl guanosine 3′,5′-cyclic monophosphate; O-mb-cGMP, 2′-O-monobutyryl guanosine 3′,5′-cyclic monophosphate; Db-cGMP, N2,2′-O-dibutyryl guanosine 3′,5′-cyclic monophosphate; Br-cGMP, 8′-bromo guanosine 3′,5′-cyclic monophosphate; Rp-cGMPS, Rp-monophosphorothioate guanosine 3′,5′-cyclic monophosphate; Sp-cGMPS, Sp-monophosphorothioate guanosine 3′,5′-cyclic monophosphate; 3′,5′-cAMP, Adenosine 3′,5′-cyclic monophosphate; and MRP, multidrug resistance protein." Biochemical Pharmacology 62, no. 4 (August 2001): 425–29. http://dx.doi.org/10.1016/s0006-2952(01)00682-7.
Full textMeskini, N., O. MacOvschi, A. F. Prigent, G. Nemoz, P. Chapuy, and M. Lagarde. "Decreased Cyclic Nucleotide Phosphodiesterase Activity in Human Peripheral Blood Mononuclear Cells from Elderly Women." Clinical Science 79, no. 5 (November 1, 1990): 467–70. http://dx.doi.org/10.1042/cs0790467.
Full textBeste, Kerstin Y., and Roland Seifert. "cCMP, cUMP, cTMP, cIMP and cXMP as possible second messengers: Development of a hypothesis based on studies with soluble guanylyl cyclase α1β1." Biological Chemistry 394, no. 2 (February 1, 2013): 261–70. http://dx.doi.org/10.1515/hsz-2012-0282.
Full textSrivastava, Uma S., Manohar Lal Thakur, and C. Spach. "Cyclic 3′, 5′-adenosine monophosphate and cyclic 3′, 5′-guanosine monophosphate metabolism in malnutrition." Nutrition Research 6, no. 5 (May 1986): 589–99. http://dx.doi.org/10.1016/s0271-5317(86)80113-0.
Full textSanty, L. C., and G. Guidotti. "Reconstitution and characterization of two forms of cyclic nucleotide-gated channels from skeletal muscle." American Journal of Physiology-Endocrinology and Metabolism 271, no. 6 (December 1, 1996): E1051—E1060. http://dx.doi.org/10.1152/ajpendo.1996.271.6.e1051.
Full textSeymour, Andrea A., Benoni Abboa-Offei, Magdi M. Asaad, and W. Lynn Rogers. "Evaluation of SQ 28 603, an inhibitor of neutral endopeptidase, in conscious monkeys." Canadian Journal of Physiology and Pharmacology 69, no. 10 (October 1, 1991): 1609–17. http://dx.doi.org/10.1139/y91-238.
Full textPradelles, Philippe, Jacques Grassi, Danielle Chabardes, and Nicole Guiso. "Enzyme immunoassays of adenosine cyclic 3',5'-monophosphate and guanosine cyclic 3',5'-monophosphate using acetylcholinesterase." Analytical Chemistry 61, no. 5 (March 1989): 447–53. http://dx.doi.org/10.1021/ac00180a014.
Full textGéigel, LF, and LL Leon. "Cyclic 3'-5' guanosine monophosphate-dependent activity in Leishmania amazonensis." Memórias do Instituto Oswaldo Cruz 98, no. 4 (June 2003): 499–500. http://dx.doi.org/10.1590/s0074-02762003000400012.
Full textŚlepokura, Katarzyna Anna. "Purine 3′:5′-cyclic nucleotides with the nucleobase in asynorientation: cAMP, cGMP and cIMP." Acta Crystallographica Section C Structural Chemistry 72, no. 6 (May 6, 2016): 465–79. http://dx.doi.org/10.1107/s2053229616006999.
Full textJackson, Edwin K., Zaichuan Mi, Keri Janesko-Feldman, Travis C. Jackson, and Patrick M. Kochanek. "2′,3′-cGMP exists in vivo and comprises a 2′,3′-cGMP-guanosine pathway." American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 316, no. 6 (June 1, 2019): R783—R790. http://dx.doi.org/10.1152/ajpregu.00401.2018.
Full textDissertations / Theses on the topic "Cyclic guanosine 3'"
Sriraman, R. "Cyclic guanosine 3', 5' - cyclic monophosphate (cGMP) enhancement & its relationship to vascular function & insulin sensitivity." Thesis, Exeter and Plymouth Peninsula Medical School, 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.701082.
Full textLi, Ying 1972 Mar 31. "The effects of cyclic guanosine 3', 5'-monophosphate analog on protein accumulation in adult rat cardiomyocytes in vitro /." Thesis, McGill University, 2007. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=101863.
Full textHamad, Ahmed El-Sayed Mansour Abd El-Mohsen. "Guanosine 3': 5'-cyclic monophosphate regulation in cultured human airway smooth muscle cells and its role in proliferation." Thesis, University of Nottingham, 1999. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.298959.
Full textCardoso, Andrea Rodrigues. "Mapeamento global de interações proteicas nas vias de sinalização mediadas por c-di-GMP de Pseudomonas aeruginosa." Universidade de São Paulo, 2016. http://www.teses.usp.br/teses/disponiveis/76/76132/tde-17052016-094656/.
Full textPersister bacteria are correlated to biofilm formation and have been a source of great medical concern due to its close association with the impairment of traditional treatment in combating chronic infections. On the other hand, using bacterial biofilms to create original biotechnological applications or even as a means of therapeutic treatment in medical settings constitutes a promising prospect. There is, therefore, a great interest in understanding the mechanisms that allow bacteria to leave the free-living planktonic lifestyle and associate in these highly complex cellular aggregates. Over the last decades, the second messenger c-di-GMP – and also the molecules involved in its synthesis (diguanylate ciclases) and degradation (phosphodiesterases) along with its receptors – has been established as a key element implicated in regulation of a series of cellular responses that determine biofilm formation or dispersion. Curiously, the proteins that play a part in the metabolism of this second messenger are frequently coded multiple times in single bacterial genomes. Taking this into account, recent studies indicate that, in order to control such a wide range of phenotypes, this system operates via high specificity of signaling – which means that the signal metabolized by a certain set of diguanylate ciclases and phosphodiesterases has specific cellular targets. Robust but yet isolated evidence indicate that a means by which a signal is segregated with its correlated phenotypic response is through direct protein-protein interaction involving the components of these signaling pathways. Even more, there has been strikingly evidence that, in some of these pathways, signal transduction occurs exclusively through protein-protein interaction, entirely dismissing any mediation by the signal molecule. In order to validate and evaluate the global relevance of this type of mechanism, this study proposed the investigation of the entire network of interactions between proteins typically associated with c-di-GMP signaling pathways of Pseudomonas aeruginosa by employing bacterial two-hybrid system assays. To make that possible, two DNA libraries were constructed and interaction essays were performed in a strategic way so that all possibilities of interaction between target proteins were explored. The results obtained from these experiments allowed the construction of a broad map of interactions that, although still primitive, indicates that, chances are, the mechanisms previously described are both recurrent and relevant to signaling regulation in this organism. Some of the interaction partners found are particularly interesting and will be further investigated in future studies.
VINELLA, DANIEL, and P. COHEN. "Le cycle cellulaire chez escherichia coli : role regulateur de la guanosine 3', 5'-tetraphosphate (ppgpp) et etude des mecanismes de partition des chromosomes." Paris 6, 1993. http://www.theses.fr/1993PA066661.
Full textHiga, Juliana Suyama 1983. "Influência do gene ycgR na regulação de fatores de virulência em amostra de Escherichia coli enteropatogênica atípica." [s.n.], 2015. http://repositorio.unicamp.br/jspui/handle/REPOSIP/317063.
Full textDissertação (mestrado) - Universidade Estadual de Campinas, Instituto de Biologia
Made available in DSpace on 2018-08-26T15:41:18Z (GMT). No. of bitstreams: 1 Higa_JulianaSuyama_M.pdf: 2740628 bytes, checksum: 20ced0f2848628f2541d4313632cfc0b (MD5) Previous issue date: 2015
Resumo: Escherichia coli (E.coli) enteropatogênica (EPEC), é um dos agentes causadores de diarreia em crianças, principalmente em países em desenvolvimento. EPEC pode ser dividida em típica (tEPEC) ou atípica (aEPEC) pela presença ou ausência do plasmídeo EAF, respectivamente e, mais precisamente pela expressão da fímbria Bfp. Uma característica de EPEC é a capacidade de causar uma lesão histopatológica denominada "attaching and effacing" (lesão A/E) no epitélio intestinal e os genes responsáveis pela formação da lesão A/E estão localizados na ilha de patogenicidade LEE (locus of enterocyte effacement). Outra característica de EPEC é a formação de microcolônias que possibilitam a formação de biofilme. Um dos mecanismos de regulação da formação de biofilme envolve a molécula sinalizadora Bis-(3'-5')-monofosfato de guanosina cíclico (c-di-GMP), um mensageiro secundário universal em bactérias que está envolvido na regulação de uma grande variedade de processos celulares. Para exercer sua função, c-di-GMP precisa se ligar e alterar alostericamente a estrutura de uma molécula efetora. Um dos receptores conhecidos para c-di-GMP é YcgR, uma proteína de domínio PilZ que possui um sítio de ligação para c-di-GMP e está envolvida diretamente na regulação do movimento flagelar através da ligação do complexo YcgR-c-di-GMP às proteínas da base do motor flagelar. Existem poucos dados na literatura sobre as funções de YcgR, todos focados apenas no seu papel na regulação da motilidade. Assim, o presente trabalho teve como objetivo avaliar a influência de YcgR na motilidade, formação de biofilme, adesão e formação de lesão A/E em um amostra de aEPEC do sorotipo O55:H7. O gene ycgR foi deletado da amostra selvagem através da técnica de recombinação homóloga proposta por Datsenko e Wanner (2000). A complementação da amostra mutante foi realizada através da clonagem do gene ycgR no plasmídeo de expressão pBAD Myc HisA. Os resultados obtidos indicam que a deleção do gene ycgR reduz a motilidade e aumenta a formação do biofilme inicial na amostra O55:H7. Além disso, a adesão em células epiteliais e a formação da lesão A/E também foram reduzidas em comparação à amostra selvagem. Os resultados fenotípicos corroboram os observados na análise transcricional dos genes eae, ler e espA, que participam da formação da lesão A/E, e dos genes bscA, fimA e csgD, envolvidos na formação do biofilme inicial. Com exceção do gene csgD que apresentou um aumento na transcrição na amostra mutante, todos os outros genes avaliados apresentaram uma menor transcrição em relação à amostra selvagem. Poucos trabalhos na literatura demonstram o papel do mensageiro secundário em amostras de E. coli patogênicas, assim, estes resultados são os primeiros descritos para uma amostra de aEPEC e possibilitam que no futuro novos estudos possam analisar com mais detalhes a participação de c-di-GMP na regulação de fatores de virulência não só de aEPEC mas também de outras E.coli patogênicas
Abstract: Enteropathogenic Escherichia coli (EPEC) is a causative agent of diarrhea in children, especially in developing countries. EPEC can be categorized in 2 subgroups termed typical (tEPEC) or atypical (aEPEC) by the presence or absence of the EAF plasmid respectively, and more precisely by the expression of the Bfp fimbriae. One characteristic of EPEC is the ability to cause a histopathological lesion on epithelial cells called "attaching and effacing" (A/E lesion). The genes responsible for the production of the A/E lesion are encoded in a pathogenicity island named "locus of enterocyte effacement" (LEE). Another feature of EPEC is the formation of microcolonies, which allow biofilm formation. One of the regulation mechanisms of biofilm formation involves the signaling molecule bis- (3'-5') cyclic guanosine monophosphate (c-di-GMP), a ubiquitous second messenger in bacteria that participates in the regulation of a wide variety of cellular processes. To perform its function, c-di-GMP needs to bind and alter allosterically the structure of an effector molecule. One of the known (many?) receptors for c-di-GMP is YcgR, a Pilz domain protein that has a c-di-GMP binding site and is involved directly in the regulation of flagellar movement through the binding of the YcgR-c-di-GMP complex to flagellar motor proteins. There are few published data on the YcgR functions and they focus mainly on the role of the YcgR in motility regulation. The aim of this study was to evaluate the influence of YcgR in motility, biofilm formation, adhesion and A/E lesion formation in an aEPEC strain serotype O55:H7. ycgR gene deletion was performed by homologous recombination as proposed by Datsenko and Wanner (2000). Complementation of O55:H7 mutant strain was achieved by cloning ycgR in pBAD/Myc-HisA plasmid. The results indicate that the deletion of ycgR gene decreases the motility and increases the formation of initial biofilm on O55:H7 strain. Moreover, the adhesion on epithelial cells and the A/E lesion formation were also diminished in comparision to the wild type strain. The phenotypic results are consistent with the transcriptional analysis of eae, ler and espA genes involved in A/E lesion formation, and of bcsA, fimA and csgD genes involved in the initial steps of biofilm formation. With the exception of csgD gene that showed an increased transcription level in the mutant strain, all other analysed genes showed a decrease in transcription when compared to the wild type strain. Few studies demonstrate the role of a second messenger molecule in Escherichia coli pathogenic samples, and therefore, these results are the first report in this regard for an aEPEC strain. This work should encourage further studies in order to analyze in more detail the involvement of c-di GMP in the regulation of virulence factors not only in aEPEC, but also in other pathogenic Escherichia coli pathotypes
Mestrado
Microbiologia
Mestra em Genética e Biologia Molecular
Lum, Min Suyin Ann. "Guanosine 3’:5’-cyclic monophosphate and contraction in vascular smooth muscle." Thesis, 1995. http://hdl.handle.net/2429/3710.
Full textSharma, Indra Mani. "Dissecting the C-DI-GMP Signaling Pathways : Tools and Tales." Thesis, 2014. http://hdl.handle.net/2005/3185.
Full textSalem, Mohamed M. A., Mohammad Shalbaf, Nick C. Gibbons, Bhavan Chavan, M. Julie Thornton, and Karin U. Schallreuter. "Enhanced DNA binding capacity on up-regulated epidermal wild-type p53 in vitiligo by H2O2-mediated oxidation: a possible repair mechanism for DNA damage." 2009. http://hdl.handle.net/10454/6168.
Full textBook chapters on the topic "Cyclic guanosine 3'"
Goldberg, Nelson D., and Ann G. O'Toole. "Analysis of Cyclic 3′,5′-Adenosine Monophosphate and Cyclic 3′,5′-Guanosine Monophosphate." In Methods of Biochemical Analysis, 1–39. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2006. http://dx.doi.org/10.1002/9780470110393.ch1.
Full textLockette, Warren, Yuji Otsuka, and Elizabeth Hirt. "The Endothelium and Cyclic Guanosine Monophosphate in Hyperthyroid-Induced Hypertension." In Vasodepressor Hormones in Hypertension: Prostaglandins and Kallikrein-Kinins, 125–32. Basel: Birkhäuser Basel, 1987. http://dx.doi.org/10.1007/978-3-0348-9299-5_13.
Full textHeinemann, L., P. T. Sawicki, G. Stroka, C. Angenvoort, A. Hohmann, and M. Berger. "Cyclic Guanosine Monophosphate Concentrations in Type 1 Diabetic Patients in Different Stages of Diabetic Nephropathy." In Endocrinology of the Heart, 195–97. Berlin, Heidelberg: Springer Berlin Heidelberg, 1989. http://dx.doi.org/10.1007/978-3-642-83858-3_34.
Full textBartsch, W., K. Strein, E. Böhm, G. Sponer, and B. Müller-Beckmann. "Isosorbide-5-Mononitrate Increases Cyclic Guanosine Monophosphate Concentration in Rat Aorta in Vitro and in Vivo." In Mononitrates, 34–38. Berlin, Heidelberg: Springer Berlin Heidelberg, 1985. http://dx.doi.org/10.1007/978-3-642-70234-1_6.
Full textCrockett, Andrew O. "Genotyping by Guanosine-Dependent Quenching of Single-Labeled Fluorescein Probes." In Rapid Cycle Real-Time PCR — Methods and Applications, 35–46. Berlin, Heidelberg: Springer Berlin Heidelberg, 2002. http://dx.doi.org/10.1007/978-3-642-59397-0_5.
Full textSAWYER, C., A. HONDA, and W. DOSTMANN. "CygnetsIntracellular Guanosine 3′,5′-Cyclic Monophosphate Sensing in Primary Cells Using Fluorescence Energy Transfer." In Cell Biology, 299–306. Elsevier, 2006. http://dx.doi.org/10.1016/b978-012164730-8/50111-8.
Full textSalter, Mark, Eric Southam, and John Garthwaite. "Nitric Oxide–Cyclic Guanosine Monophosphate Pathway in Central Nervous System: In Vitro and in Vivo Investigations." In Methods in Neurosciences, 241–52. Elsevier, 1996. http://dx.doi.org/10.1016/s1043-9471(96)80024-3.
Full text